Browsing: Cancer

Discover how cancer survivors like Sabrina navigate mental health challenges, with insights and resources from 365 Cancer Prevention Society.

Groundbreaking CD7 CAR-T therapy from NUS Medicine offers hope for T-cell acute lymphoblastic leukaemia (T-ALL) patients. Early case reports show 16 of 17 achieved remission, marking a significant cancer treatment advancement for relapsed/refractory T-ALL.

Three T-ALL patients – Viet Tai, Maria, and Hannah – share their inspiring cancer journeys through an innovative CD7 CAR-T therapy treatment, pioneered by researchers and clinicians from the NUS Medicine and NUHS and cultivated in-house by a modest laboratory in Singapore.

Health Rounds: A study in mice suggested transplanting eggs from older ovaries into younger tissue could rejuvenate them and improve IVF outcomes. Researchers found a gene variant that protects some babies from jaundice by better processing bilirubin. A trial demonstrated Exelixis’ Cabometyx extended progression-free survival for patients with advanced pancreatic neuroendocrine tumours resistant to other treatments.

Two ESMO 2024 studies provided reassuring findings on breastfeeding for breast cancer survivors. A study of nearly 5,000 young BRCA mutation carriers and another of 518 women who interrupted treatment to have a baby both found no increased recurrence risk among those who breastfed their babies compared to those who did not breastfeed.

In an emotional video message, Kate Middleton reflected on the challenges of her cancer journey and her focus on staying cancer-free post chemotherapy treatment. Her journey serves as a powerful reminder of the importance of early detection and proactive healthcare.

The inaugural IHH Singapore Sea Regatta 2024 raises awareness for breast cancer. Featuring healthcare races, free mammograms and festival activities landside, the event aims to educate the public on breast health and active ageing through a vibrant two-day celebration at the Singapore Sports Hub.

From 1 August 2024, Singapore’s Ministry of Health has introduced substantial subsidies for high-cost cell, tissue, and gene therapies, providing a lifeline for patients needing advanced treatments such as CAR T-cell therapy. The subsidies are aimed at making these treatments more accessible by adjusting the coverage based on household income and patient needs, with caps of up to $150,000 for citizens and $45,000 for permanent residents

Log In or Register as a healthcare professional to read the full article.

Log In or Register as a healthcare professional to read the full article.